These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26272706)

  • 21. Uptake of botulinum neurotoxin in the intestine.
    Fujinaga Y; Sugawara Y; Matsumura T
    Curr Top Microbiol Immunol; 2013; 364():45-59. PubMed ID: 23239348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembly and function of the botulinum neurotoxin progenitor complex.
    Gu S; Jin R
    Curr Top Microbiol Immunol; 2013; 364():21-44. PubMed ID: 23239347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.
    Hasegawa K; Watanabe T; Suzuki T; Yamano A; Oikawa T; Sato Y; Kouguchi H; Yoneyama T; Niwa K; Ikeda T; Ohyama T
    J Biol Chem; 2007 Aug; 282(34):24777-83. PubMed ID: 17581814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B; Colliou N; Zadeh M; Ge Y; Gong M; Owen JL; Valletti M; Jobin C; Mohamadzadeh M
    Vaccine; 2018 Jan; 36(1):155-164. PubMed ID: 29180028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.
    Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S
    Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.
    Yoneyama T; Miyata K; Chikai T; Mikami A; Suzuki T; Hasegawa K; Ikeda T; Watanabe T; Ohyama T; Niwa K
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):290-8. PubMed ID: 18801042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.
    Yao G; Lam KH; Perry K; Weisemann J; Rummel A; Jin R
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28282873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
    Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G; Lam KH; Weisemann J; Peng L; Krez N; Perry K; Shoemaker CB; Dong M; Rummel A; Jin R
    Sci Rep; 2017 Aug; 7(1):7438. PubMed ID: 28785006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex.
    Sagane Y; Hayashi S; Akiyama T; Matsumoto T; Hasegawa K; Yamano A; Suzuki T; Niwa K; Watanabe T; Yajima S
    Biochem Biophys Res Commun; 2016 Aug; 476(4):280-285. PubMed ID: 27237978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells.
    Niwa K; Yoneyama T; Ito H; Taira M; Chikai T; Kouguchi H; Suzuki T; Hasegawa K; Miyata K; Inui K; Ikeda T; Watanabe T; Ohyama T
    Vet Microbiol; 2010 Mar; 141(3-4):312-20. PubMed ID: 19786330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.
    You Z; Yang H; Xin W; Kang L; Gao S; Wang J; Zhang T; Wang J
    Hum Vaccin Immunother; 2014; 10(8):2321-7. PubMed ID: 25424938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption.
    Matsumura T; Jin Y; Kabumoto Y; Takegahara Y; Oguma K; Lencer WI; Fujinaga Y
    Cell Microbiol; 2008 Feb; 10(2):355-64. PubMed ID: 17868282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
    Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
    Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxication.
    Guo J; Wang J; Gao S; Ji B; Waichi Chan E; Chen S
    Sci Rep; 2015 Nov; 5():16981. PubMed ID: 26584873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity.
    Matsumura T; Sugawara Y; Yutani M; Amatsu S; Yagita H; Kohda T; Fukuoka S; Nakamura Y; Fukuda S; Hase K; Ohno H; Fujinaga Y
    Nat Commun; 2015 Feb; 6():6255. PubMed ID: 25687350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.
    Cheng LW; Henderson TD
    Toxicon; 2011 Jul; 58(1):62-7. PubMed ID: 21600236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translocation and dissemination of botulinum neurotoxin from the intestinal tract.
    Fujinaga Y; Popoff MR
    Toxicon; 2018 Jun; 147():13-18. PubMed ID: 29074396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.
    Connan C; Voillequin M; Chavez CV; Mazuet C; Leveque C; Vitry S; Vandewalle A; Popoff MR
    Cell Microbiol; 2017 Aug; 19(8):. PubMed ID: 28296078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.